Literature DB >> 32451910

Mu-Opioid Receptors Expressed in Glutamatergic Neurons are Essential for Morphine Withdrawal.

Xin-Yan Zhang1,2, Qing Li1, Ye Dong1, Wei Yan1,2, Kun Song1,2, Yong-Qin Lin1,2, Yan-Gang Sun3.   

Abstract

Although opioids still remain the most powerful pain-killers, the chronic use of opioid analgesics is largely limited by their numerous side-effects, including opioid dependence. However, the mechanism underlying this dependence is largely unknown. In this study, we used the withdrawal symptoms precipitated by naloxone to characterize opioid dependence in mice. We determined the functional role of mu-opioid receptors (MORs) expressed in different subpopulations of neurons in the development of morphine withdrawal. We found that conditional deletion of MORs from glutamatergic neurons expressing vesicular glutamate transporter 2 (Vglut2+) largely eliminated the naloxone-precipitated withdrawal symptoms. In contrast, conditional deletion of MORs expressed in GABAergic neurons had a limited effect on morphine withdrawal. Consistently, mice with MORs deleted from Vglut2+ glutamatergic neurons also showed no morphine-induced locomotor hyperactivity. Furthermore, morphine withdrawal and morphine-induced hyperactivity were not significantly affected by conditional knockout of MORs from dorsal spinal neurons. Taken together, our data indicate that the development of morphine withdrawal is largely mediated by MORs expressed in Vglut2+ glutamatergic neurons.

Entities:  

Keywords:  Dorsal spinal cord; Locomotor hyperactivity; Morphine; Mu-opioid receptor; Naloxone-precipitated withdrawal

Mesh:

Substances:

Year:  2020        PMID: 32451910      PMCID: PMC7532259          DOI: 10.1007/s12264-020-00515-5

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  38 in total

Review 1.  Opioid Receptors.

Authors:  Christoph Stein
Journal:  Annu Rev Med       Date:  2015-08-26       Impact factor: 13.739

2.  Morphine withdrawal recruits lateral habenula cytokine signaling to reduce synaptic excitation and sociability.

Authors:  Kristina Valentinova; Anna Tchenio; Massimo Trusel; Joseph A Clerke; Arnaud L Lalive; Stamatina Tzanoulinou; Alessandro Matera; Imane Moutkine; Luc Maroteaux; Rosa C Paolicelli; Andrea Volterra; Camilla Bellone; Manuel Mameli
Journal:  Nat Neurosci       Date:  2019-06-17       Impact factor: 24.884

3.  Sucrose preference test for measurement of stress-induced anhedonia in mice.

Authors:  Meng-Ying Liu; Chun-Yu Yin; Li-Juan Zhu; Xian-Hui Zhu; Chu Xu; Chun-Xia Luo; Hongshan Chen; Dong-Ya Zhu; Qi-Gang Zhou
Journal:  Nat Protoc       Date:  2018-07       Impact factor: 13.491

4.  A neural circuit for comorbid depressive symptoms in chronic pain.

Authors:  Wenjie Zhou; Yan Jin; Qian Meng; Xia Zhu; Tongjian Bai; Yanghua Tian; Yu Mao; Likui Wang; Wen Xie; Hui Zhong; Na Zhang; Min-Hua Luo; Wenjuan Tao; Haitao Wang; Jie Li; Juan Li; Ben-Sheng Qiu; Jiang-Ning Zhou; Xiangyao Li; Han Xu; Kai Wang; Xiaochu Zhang; Yong Liu; Gal Richter-Levin; Lin Xu; Zhi Zhang
Journal:  Nat Neurosci       Date:  2019-08-26       Impact factor: 24.884

5.  The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats.

Authors:  Vasudeva Raghavendra; Maria D Rutkowski; Joyce A DeLeo
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

6.  UMB-3, a novel rabbit monoclonal antibody, for assessing μ-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues.

Authors:  Amelie Lupp; Nadine Richter; Christian Doll; Falko Nagel; Stefan Schulz
Journal:  Regul Pept       Date:  2010-09-17

7.  Mu Opioid Receptors in Gamma-Aminobutyric Acidergic Forebrain Neurons Moderate Motivation for Heroin and Palatable Food.

Authors:  Pauline Charbogne; Olivier Gardon; Elena Martín-García; Helen L Keyworth; Aya Matsui; Anna E Mechling; Thomas Bienert; Md Taufiq Nasseef; Anne Robé; Luc Moquin; Emmanuel Darcq; Sami Ben Hamida; Patricia Robledo; Audrey Matifas; Katia Befort; Claire Gavériaux-Ruff; Laura-Adela Harsan; Dominik von Elverfeldt; Jurgen Hennig; Alain Gratton; Ian Kitchen; Alexis Bailey; Veronica A Alvarez; Rafael Maldonado; Brigitte L Kieffer
Journal:  Biol Psychiatry       Date:  2016-12-26       Impact factor: 13.382

Review 8.  Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics.

Authors:  Tuan Trang; Ream Al-Hasani; Daniela Salvemini; Michael W Salter; Howard Gutstein; Catherine M Cahill
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

9.  Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.

Authors:  Gregory Corder; Vivianne L Tawfik; Dong Wang; Elizabeth I Sypek; Sarah A Low; Jasmine R Dickinson; Chaudy Sotoudeh; J David Clark; Ben A Barres; Christopher J Bohlen; Grégory Scherrer
Journal:  Nat Med       Date:  2017-01-16       Impact factor: 53.440

10.  Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence.

Authors:  Theresa Alexandra Mattioli; Heather Leduc-Pessah; Graham Skelhorne-Gross; Chris J B Nicol; Brian Milne; Tuan Trang; Catherine M Cahill
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

View more
  3 in total

1.  Simvastatin Blocks Reinstatement of Cocaine-induced Conditioned Place Preference in Male Mice with Brain Lipidome Remodeling.

Authors:  Wei Xu; Yuman He; Jiamei Zhang; Hongchun Li; Xuemei Wan; Menglu Li; Yonghai Wang; Rui Xu; Haoluo Zhang; Yanping Dai; Haxiaoyu Liu; Linhong Jiang; Ying Zhao; Xiaobo Cen
Journal:  Neurosci Bull       Date:  2021-09-07       Impact factor: 5.203

2.  GPR171 activation regulates morphine tolerance but not withdrawal in a test-dependent manner in mice.

Authors:  Leela Afrose; Max V McDermott; Ashif I Bhuiyan; Sanjai K Pathak; Erin N Bobeck
Journal:  Behav Pharmacol       Date:  2022-08-05       Impact factor: 2.277

3.  Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids.

Authors:  Xin-Yan Zhang; Yan-Nong Dou; Lei Yuan; Qing Li; Yan-Jing Zhu; Meng Wang; Yan-Gang Sun
Journal:  Elife       Date:  2020-06-10       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.